临床经验
Copyright ©The Author(s) 2005.
世界华人消化杂志. 2005-08-28; 13(16): 2050-2051
在线出版 2005-08-28. doi: 10.11569/wcjd.v13.i16.2050
表1 肝硬化腹水患者的临床特点(mean±SD)
指标Diuretics-responsive (n = 18)Diuretics-unresponsive (n = 18)
Age(yr)57.0±2.957.7±2.7
Sex(M/F)6/27/1
Child-Pugh score10.9±0.711.8±0.74
Hb(g/L)89.0±4.092.0±5.0
Platelet(×109/L)60.0±17.563.8±11.4
Serum albumin(g/L)27.0±1.228.0±2.1
Serum bilirubin(umol/L)78.7±23.971.8±17.1
ALT(U/L)32.6±8.818.6±2.6
AST(U/L)43.5±4.135.6±0.2
Serum Na(mmol/L)137.4±1.0134.1±1.4
PT(INR)2.2±0.22.2±0.3
Spot urine Na(mmol/L)109.1±17.757.7±13.4a
Spot urine K(mmol/L)24.0±4.427.4±7.3
Spot urine Cl(mmol/L)62.6±13.870.2±10.9
Spot urine Osmolarity(mOsm/kgH2O)319.4±52.5306.6±56.1
Creatinine clearance(mL/min)62.2±11.249.6±7.2
表2 肝硬化腹水患者80mg速尿静脉推注后两组间的比较(mean±SD)
指标Diuretics-responsive (n = 18)Diuretics-unresponsive (n = 18)
3rd experiment day
24 h urine volume(mL)1 351.3±173.7637.5±101.5b
24 h urine sodium(mmol)125.0±18.1763.6±11.8a
After furosemide IV
8 h urine volume(mL)2 003.7±114.61 297.5±80.9b
8 h urine sodium(mmol)211.8±12.677.3±8.2b

引文著录: 韩学吉, 许顺姬, 崔鹤松. 肝硬化腹水治疗中测定尿钠的意义. 世界华人消化杂志 2005; 13(16): 2050-2051